New Treatment for Gout in Elderly with Kidney Issues
Author Information
Author(s): Anne-Kathrin Tausche, Carsten Wunderlich, Martin Aringer
Primary Institution: University Clinic “Carl Gustav Carus” of the Technical University of Dresden
Conclusion
The treatment with febuxostat successfully controlled serum uric acid levels, stopped gout attacks, and resolved tophi in the patient.
Supporting Evidence
- The patient had recurrent gouty arthritis for 4 years with high serum uric acid levels.
- Allopurinol was ineffective due to intolerance, and benzbromarone was ineffective due to renal impairment.
- Febuxostat treatment led to a rapid decrease in serum urate levels.
Takeaway
An 87-year-old woman with severe gout and kidney problems was treated with a new medicine called febuxostat, which helped her feel better and reduced her gout symptoms.
Methodology
The patient was treated with febuxostat and monitored for changes in serum uric acid levels and gout symptoms.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
An 87-year-old woman with chronic tophaceous gout and renal insufficiency.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website